𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bone marrow transplantation with high-dose cytosine arabinoside

✍ Scribed by Herzig, R. H. ;Lazarus, H. M. ;Graham-Pole, J. ;Gross, S. ;Coccia, P. ;Gordon, E. M. ;Strandjord, S. ;Phillips, G. L. ;Herzig, G. P.


Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
243 KB
Volume
10
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Eleven patients received allogeneic bone marrow from all HCA-identical sibling for the treatment of acute leukemia. The preparative regiment included high-dose cytosine arabinoside (Ara-C), 3 g/m2q 12 h for 12 doses, and lo00 rad singlefraction total body irradiation (5 patients) or 1200 rad fractionated total body irradiation (6 patients). The 5 patients receiving the lo00 rad single-fraction regimen were transplanted in relapse, while the 6 patients receiving the 1200 rad fractionated program were transplanted during remission. Both regimens were well-tolerated, but the single-dose radiation regimen was associated with more severe skin problems. Bone marrow engraftment was documented in 10 of 10 evaluable patients, occurring 2-3 weeks after marrow infusion. No recurrences have been observed during the brief follow-up time.


πŸ“œ SIMILAR VOLUMES


Fractionated total-body irradiation prec
✍ Kamani, Naynesh ;Bayever, Eliel ;August, Charles S. ;Bunin, Nancy ;Goldwein, Joe πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 473 KB πŸ‘ 1 views

## Abstract Twenty children with acute leukemia between 3 and 19 years of age underwent allogeneic bone marrow transplantation from HLA‐matched sibling donors after conditioning with total‐body irradiation (1,200 cGy in six fractions of 200 cGy twice daily for 3 days) and high dose cytosine arabino

Parkisonism induced by high-dose cytosin
✍ Dr. F. Antonio Luque; John B. Selhorst; Paul Petruska πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 280 KB

We report a severe parkinsonian condition following high dose, parenteral cytosine arabinoside (Cytosar) that persisted for 8 weeks. The drug was used in a patient with acute myelogenous leukemia that was refractory to all other treatment. The syndrome was partially responsive to antiparkinsonian dr